Cargando…

Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’

Detalles Bibliográficos
Autores principales:	Shukla, Ajay Kumar, Jhaj, Ratinder, Sadasivam, Balakrishnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923971/ https://www.ncbi.nlm.nih.gov/pubmed/33717432 http://dx.doi.org/10.1177/2045125321997293

Ejemplares similares

Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?
por: Faden, Justin, et al.
Publicado: (2020)

Efficacy of brexanolone in postpartum depression
por: Rodríguez Mercado, C. M.
Publicado: (2023)

Treating Postpartum Depression: What Do We Know about Brexanolone?
por: Ali, Muneeza, et al.
Publicado: (2021)

Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
por: Garafola, Svetlana, et al.
Publicado: (2023)

Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
por: Kanes, Stephen J., et al.
Publicado: (2017)

Patient-reported perceptions of brexanolone in the treatment of postpartum depression: A qualitative analysis
por: Salwan, Aaron, et al.
Publicado: (2023)

Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making
por: Gerbasi, Margaret E., et al.
Publicado: (2021)

Brexanolone, a GABA(A) Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review
por: Edinoff, Amber N., et al.
Publicado: (2021)

Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States
por: Eldar-Lissai, Adi, et al.
Publicado: (2020)

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
por: Reddy, Doodipala Samba, et al.
Publicado: (2023)

Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways
por: Balan, Irina, et al.
Publicado: (2023)

Brexanolone as adjunctive therapy in super‐refractory status epilepticus
por: Rosenthal, Eric S., et al.
Publicado: (2017)

Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression
por: Cooper, Miranda C., et al.
Publicado: (2019)

Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience
por: Lüscher, Bernhard, et al.
Publicado: (2019)

Fixed-drug Eruptions: What can we Learn from a Case Series?
por: Jhaj, Ratinder, et al.
Publicado: (2018)

Inadequate pain relief for patients with trauma: A cause for concern?
por: Balakrishnan, Sadasivam, et al.
Publicado: (2013)

Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose
por: Wald, Jeffrey, et al.
Publicado: (2022)

Regression of the Left Ventricular Hypertrophy in Patients with Essential Hypertension on Standard Drug Therapy
por: Ahmed, Shah Newaz, et al.
Publicado: (2020)

Prediction of Left Ventricular Mass Index Using Electrocardiography in Essential Hypertension – A Multiple Linear Regression Model
por: Ahmed, Shah Newaz, et al.
Publicado: (2020)

Reversal of hypertensive heart disease: a multiple linear regression model
por: Ahmed, Shah Newaz, et al.
Publicado: (2021)

Topical steroid containing combinations: Burden of adverse effects and why the recent regulatory action may not be enough
por: Jhaj, Ratinder, et al.
Publicado: (2021)

Tigecycline-Induced Severe Hypoglycemia in a Non-Diabetic Individual: A Case Report and Brief Review of Tigecycline-Induced Severe Hypoglycemia
por: Ray, Avik, et al.
Publicado: (2020)

Risperidone-induced Somnambulism: A Case Report and Brief Review of Literature
por: Najmi, Ahmad, et al.
Publicado: (2020)

Anti-inflammatory and arthritic activity of zaltoprofen compared to piroxicam in murine models
por: Sadasivam, Balakrishnan, et al.
Publicado: (2022)

Allopregnanolone in Postpartum Depression
por: Pinna, Graziano, et al.
Publicado: (2022)

The Association between Postpartum Practice and Chinese Postpartum Depression: Identification of a Postpartum Depression-Related Dietary Pattern
por: Zhao, Ai, et al.
Publicado: (2022)

Positive postpartum well‐being: What works for women
por: Hannon, Susan, et al.
Publicado: (2022)

A pilot point prevalence study of antimicrobial drugs in indoor patients of a teaching hospital in Central India
por: Najmi, Ahmad, et al.
Publicado: (2019)

Delineating the Association between Heavy Postpartum Haemorrhage and Postpartum Depression
por: Eckerdal, Patricia, et al.
Publicado: (2016)

Association between Postpartum Nutritional Status and Postpartum Depression Symptoms
por: Lin, Yu-Hung, et al.
Publicado: (2019)

Depression in Pregnancy and Postpartum Period
por: Sood, Mamta, et al.
Publicado: (2003)

Postpartum depression and suicide in Iran
por: Bagheri, Parnia, et al.
Publicado: (2021)

Risk factors of postpartum depression
por: Dubey, Amresh, et al.
Publicado: (2021)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Familial risk of postpartum depression
por: Rasmussen, Marie‐Louise H., et al.
Publicado: (2022)

Risk Factors of Postpartum Depression
por: Agrawal, Iris, et al.
Publicado: (2022)

Timing of Postpartum Depressive Symptoms
por: Robbins, Cheryl L., et al.
Publicado: (2023)

Anxiety During Pregnancy and Postpartum: Course, Predictors and Comorbidity with Postpartum Depression
por: Radoš, Sandra Nakić, et al.
Publicado: (2018)

Postpartum depression: bipolar or unipolar? Analysis of 434 Polish postpartum women
por: Jaeschke, Rafał R., et al.
Publicado: (2016)

Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
por: Bombač Tavčar, Lea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tq6phk2qgn8spq7st1bjfeabq4